ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 79 filers reported holding ORIC PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $248,185 | +360.0% | 35,104 | +794.6% | 0.00% | – |
| Q1 2024 | $53,955 | -8.7% | 3,924 | -38.9% | 0.00% | – |
| Q4 2023 | $59,110 | +13.4% | 6,425 | -25.4% | 0.00% | – |
| Q3 2023 | $52,103 | -48.3% | 8,612 | -33.7% | 0.00% | – |
| Q2 2023 | $100,756 | -47.5% | 12,984 | -63.9% | 0.00% | – |
| Q1 2022 | $192,000 | -66.0% | 35,968 | -6.4% | 0.00% | -100.0% |
| Q4 2021 | $565,000 | -25.9% | 38,428 | +5.4% | 0.00% | 0.0% |
| Q3 2021 | $762,000 | +5.8% | 36,443 | -10.4% | 0.00% | 0.0% |
| Q2 2021 | $720,000 | -13.8% | 40,685 | +19.3% | 0.00% | 0.0% |
| Q1 2021 | $835,000 | -26.5% | 34,089 | +1.6% | 0.00% | -50.0% |
| Q4 2020 | $1,136,000 | +246.3% | 33,559 | +155.6% | 0.00% | +100.0% |
| Q3 2020 | $328,000 | -26.0% | 13,129 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $443,000 | – | 13,129 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 496,893 | $16,760,000 | 14.90% |
| Svennilson Peter | 4,768,181 | $160,831,000 | 13.45% |
| Invus Financial Advisors, LLC | 1,007,576 | $33,986,000 | 12.28% |
| EcoR1 Capital, LLC | 2,642,218 | $89,122,000 | 6.58% |
| Foresite Capital Management IV, LLC | 125,000 | $4,216,000 | 2.05% |
| Orbimed Advisors | 2,921,967 | $98,558,000 | 1.39% |
| Casdin Capital, LLC | 251,515 | $8,484,000 | 0.50% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 191,568 | $6,462,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 300,000 | $10,119,000 | 0.30% |
| EMERALD ADVISERS, LLC | 186,140 | $6,279,000 | 0.27% |